709 related articles for article (PubMed ID: 30445005)
21. Advanced Pharmaceutical Applications of Hot-Melt Extrusion Coupled with Fused Deposition Modelling (FDM) 3D Printing for Personalised Drug Delivery.
Tan DK; Maniruzzaman M; Nokhodchi A
Pharmaceutics; 2018 Oct; 10(4):. PubMed ID: 30356002
[TBL] [Abstract][Full Text] [Related]
22. A Lower Temperature FDM 3D Printing for the Manufacture of Patient-Specific Immediate Release Tablets.
Okwuosa TC; Stefaniak D; Arafat B; Isreb A; Wan KW; Alhnan MA
Pharm Res; 2016 Nov; 33(11):2704-12. PubMed ID: 27506424
[TBL] [Abstract][Full Text] [Related]
23. Polymers for Extrusion-Based 3D Printing of Pharmaceuticals: A Holistic Materials-Process Perspective.
Azad MA; Olawuni D; Kimbell G; Badruddoza AZM; Hossain MS; Sultana T
Pharmaceutics; 2020 Feb; 12(2):. PubMed ID: 32028732
[TBL] [Abstract][Full Text] [Related]
24. Design and characterization of a novel 3D printed pressure-controlled drug delivery system.
Krause J; Bogdahn M; Schneider F; Koziolek M; Weitschies W
Eur J Pharm Sci; 2019 Dec; 140():105060. PubMed ID: 31499171
[TBL] [Abstract][Full Text] [Related]
25. 3D printed oral theophylline doses with innovative 'radiator-like' design: Impact of polyethylene oxide (PEO) molecular weight.
Isreb A; Baj K; Wojsz M; Isreb M; Peak M; Alhnan MA
Int J Pharm; 2019 Jun; 564():98-105. PubMed ID: 30974194
[TBL] [Abstract][Full Text] [Related]
26. M3DISEEN: A novel machine learning approach for predicting the 3D printability of medicines.
Elbadawi M; Muñiz Castro B; Gavins FKH; Ong JJ; Gaisford S; Pérez G; Basit AW; Cabalar P; Goyanes A
Int J Pharm; 2020 Nov; 590():119837. PubMed ID: 32961295
[TBL] [Abstract][Full Text] [Related]
27. Filament-based 3D-printing of placebo dosage forms using brittle lipid-based excipients.
Abdelhamid M; Koutsamanis I; Corzo C; Maisriemler M; Ocampo AB; Slama E; Alva C; Lochmann D; Reyer S; Freichel T; Salar-Behzadi S; Spoerk M
Int J Pharm; 2022 Aug; 624():122013. PubMed ID: 35839981
[TBL] [Abstract][Full Text] [Related]
28. Development of immediate release (IR) 3D-printed oral dosage forms with focus on industrial relevance.
Fanous M; Gold S; Hirsch S; Ogorka J; Imanidis G
Eur J Pharm Sci; 2020 Dec; 155():105558. PubMed ID: 32946957
[TBL] [Abstract][Full Text] [Related]
29. Preformulation Studies to Guide the Production of Medicines by Fused Deposition Modeling 3D Printing.
Pinho LAG; Lima AL; Sa-Barreto LL; Gratieri T; Gelfuso GM; Marreto RN; Cunha-Filho M
AAPS PharmSciTech; 2021 Nov; 22(8):263. PubMed ID: 34729662
[TBL] [Abstract][Full Text] [Related]
30. Determination of feed forces to improve process understanding of Fused Deposition Modeling 3D printing and to ensure mass conformity of printed solid oral dosage forms.
Gottschalk N; Quodbach J; Elia AG; Hess F; Bogdahn M
Int J Pharm; 2022 Feb; 614():121416. PubMed ID: 34958898
[TBL] [Abstract][Full Text] [Related]
31. Printfills: 3D printed systems combining fused deposition modeling and injection volume filling. Application to colon-specific drug delivery.
Linares V; Casas M; Caraballo I
Eur J Pharm Biopharm; 2019 Jan; 134():138-143. PubMed ID: 30476539
[TBL] [Abstract][Full Text] [Related]
32. Direct powder extrusion 3D printing: Fabrication of drug products using a novel single-step process.
Goyanes A; Allahham N; Trenfield SJ; Stoyanov E; Gaisford S; Basit AW
Int J Pharm; 2019 Aug; 567():118471. PubMed ID: 31252147
[TBL] [Abstract][Full Text] [Related]
33. 3D printing in the design of pharmaceutical dosage forms.
Souto EB; Campos JC; Filho SC; Teixeira MC; Martins-Gomes C; Zielinska A; Carbone C; Silva AM
Pharm Dev Technol; 2019 Oct; 24(8):1044-1053. PubMed ID: 31180272
[TBL] [Abstract][Full Text] [Related]
34. Fabrication of timed-release indomethacin core-shell tablets for chronotherapeutic drug delivery using dual nozzle fused deposition modeling (FDM) 3D printing.
Chung S; Zhang P; Repka MA
Eur J Pharm Biopharm; 2023 Jul; 188():254-264. PubMed ID: 37201727
[TBL] [Abstract][Full Text] [Related]
35. Performance and paroxetine stability in tablets manufactured by fused deposition modelling-based 3D printing.
Figueiredo S; Fernandes AI; Carvalho FG; Pinto JF
J Pharm Pharmacol; 2022 Jan; 74(1):67-76. PubMed ID: 34591102
[TBL] [Abstract][Full Text] [Related]
36. Emergence of 3D Printed Dosage Forms: Opportunities and Challenges.
Alhnan MA; Okwuosa TC; Sadia M; Wan KW; Ahmed W; Arafat B
Pharm Res; 2016 Aug; 33(8):1817-32. PubMed ID: 27194002
[TBL] [Abstract][Full Text] [Related]
37. Controlled Release of 5-Fluorouracil from Alginate Beads Encapsulated in 3D Printed pH-Responsive Solid Dosage Forms.
Gioumouxouzis CI; Chatzitaki AT; Karavasili C; Katsamenis OL; Tzetzis D; Mystiridou E; Bouropoulos N; Fatouros DG
AAPS PharmSciTech; 2018 Nov; 19(8):3362-3375. PubMed ID: 29948989
[TBL] [Abstract][Full Text] [Related]
38. 3D printing hybrid materials using fused deposition modelling for solid oral dosage forms.
Krueger L; Miles JA; Popat A
J Control Release; 2022 Nov; 351():444-455. PubMed ID: 36184971
[TBL] [Abstract][Full Text] [Related]
39. Rheology as a tool for evaluation of melt processability of innovative dosage forms.
Aho J; Boetker JP; Baldursdottir S; Rantanen J
Int J Pharm; 2015 Oct; 494(2):623-642. PubMed ID: 25666026
[TBL] [Abstract][Full Text] [Related]
40. Adaptation of pharmaceutical excipients to FDM 3D printing for the fabrication of patient-tailored immediate release tablets.
Sadia M; Sośnicka A; Arafat B; Isreb A; Ahmed W; Kelarakis A; Alhnan MA
Int J Pharm; 2016 Nov; 513(1-2):659-668. PubMed ID: 27640246
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
